Surims Ltd Logo

Search the global news on our network companies

A comprehensive source of news from our network. With the latest from companies appearing on our platform, around the globe, we deliver an extensive summary of news, press releases and information directly from the companies and other authoritative industry news sources.

Search and filter the results by company or location to find the news that matters to you.

If you would like to publish news on behalf of your company, please register with us at the following link  

Search Term

Save This Search | View as Grid | Order by Recently Added | Order by Company Name

  • Total Results: 1,017
  • Total Pages: 128
Evotec AG Logo
Evotec AG - 12 Jul 2024
Evotec and Pfizer collaborate to advance drug discovery in France
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced it has entered into a multi-year master research collaboration and option and license agreement with Pfizer. Under the agreement, Evotec and Pfizer will initially focus on early discovery research for metabolic and infectious diseases.

View original story »

Manage Your Profile
Just-Evotec Logo
Just-Evotec - 11 Jul 2024
Just – Evotec Biologics selected by U.S. Department of Defense
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Seattle-based subsidiary, Just – Evotec Biologics, Inc., was selected by the U.S. Department of Defense (“DOD”) to develop an accelerated monoclonal antibody (“mAb”) development and manufacturing solution for the DOD’s Manufacturing Optimization Program. The multi-year program award, valued up to $ 39 m, will support the U.S. Government’s effort to enhance its rapid response capabilities for biologics medical countermeasures (“MCMs”).

Read more on this story »

Manage Your Profile
Bio Farma Logo
Bio Farma - 11 Jul 2024
Novo Nordisk, Indonesia's Bio Farma sign deal to package insulin
JAKARTA, July 10 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new…

Read more on this story »

Manage Your Profile
IASO BioTherapeutics Logo
IASO BioTherapeutics - 09 Jul 2024
IASO Bio and Innovent Enhance Strategic Collaboration in Cell Therapy
NANJING, SHANGHAI, CHINA, and SAN JOSE, CA., U.S., July 5, 2024 – IASO Biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody products, and Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology, and other major diseases, jointly announced the agreement on a series of cooperation, including IASO Bio's…

Read more on this story »

Manage Your Profile
Aptamer Group Logo
Aptamer Group - 07 Jul 2024
Aptamer is pleased to announce a new agreement with AstraZeneca
 Aptamer is pleased to announce a new agreement with AstraZeneca, a global biopharmaceutical company, to evaluate the Optimer fibrotic liver delivery vehicles for the targeted delivery of siRNA.
Following the encouraging results achieved to-date with Aptamer’s fibrotic liver delivery vehicles, the next phase of this research will explore the potential of the non-viral delivery vehicle and its applicability with a tool siRNA.

View original story »

Manage Your Profile
Pendopharm Logo
Pendopharm - 06 Jul 2024
Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S
MONTREAL, July 4, 2024 /CNW/ - Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S (NASDAQ:ASND) ("Ascendis"), a global biopharmaceutical company headquartered…

Read more on this story »

Manage Your Profile
Nova Pharma Solutions Logo
Nova Pharma Solutions - 05 Jul 2024
Nova Pharma awarded contract from National Institute of Biotechnology
Nova Pharma Solutions Bhd has been awarded a contract by the National Institute of Biotechnology Malaysia (NIBM) to procure equipment and upgrade facilities for NIBM’s national vaccine production development program. The project will be carried out at the Malaysia Genome & Vaccine Institute within NIBM’s premises in Kajang. While the exact contract value was not disclosed, Nova Pharma intends to finance the project through internal funds and…

Read more on this story »

Manage Your Profile
Nxera Pharma Logo
Nxera Pharma - 05 Jul 2024
Nxera Pharma receives US$10 million from AbbVie as collaboration targeting neurological diseases achieves first R&D milestone
Tokyo, Japan and Cambridge, UK, 27 June 2024 - Nxera Pharma Co. Ltd, announces that it has reached an important R&D milestone under its multi-target discovery collaboration with AbbVie targeting neurological diseases, resulting in a payment of US$10 million to Nxera. Nxera and AbbVie entered into this multi-target collaboration in 2022 to leverage Nxera’s NxWave™ platform to…

Read more on this story »

Manage Your Profile
  • Total Results: 1,017
  • Total Pages: 128

Network News

Keeping the latest and up-to-date news on our companies is a key activity of the editorial team.

We support companies directly through the profiles to allow them update their profile with the latest news and company announcements. Search fields are provided so that you can access news by company name, sector e.g research, manufacturing, equipment, packaging or geography. 

The global news is updated daily and its aim is to provide you as a directory user with the information needed to make good buying or supply choices. News covers companies operating within the pharmaceutical, biotechnology, medical device and nutraceutical sectors. 

Also through our software applications you can evaluate, rate and score news and company announcements to support corporate risk management activities. Through the software applications it is possible to supplement and add your own news items, keeping a library of news activities on any company identified through the directory. 

Take the Next Step

Should you have any questions or require further information please contact us ...
Contact the support team »

Check if your company is listed and claim your online profile ...
Search for your company listing »

If you're not listed in the directory and you want to build a public profile, register for an account ...
Register for an account to build a profile »

Apply for a free trial of our Supplier Management Software ...
Register for an account to trial the software »


About Us

The Partnership Tree established in 2003 (initially a pharmaceutical company directory) supporting companies in the finding, qualification and management of quality vendors and technical partners in the pharmaceutical. biotech and medical devices industry.

The Partnership Tree supports the finding and egagement with technical and commercial partners. It also incorporates software applications that support successful partner engagement and management. These include the building and deployment of questionnaires and assessments for vendor qualification, document excahnge, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at 


Get in Touch

The Partnership Tree


© 2024 Surims Ltd | All Rights Reserved.